Snyder v. UnitedHealth Group, Inc.

CourtDistrict Court, D. Minnesota
DecidedDecember 2, 2021
Docket0:21-cv-01049
StatusUnknown

This text of Snyder v. UnitedHealth Group, Inc. (Snyder v. UnitedHealth Group, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Snyder v. UnitedHealth Group, Inc., (mnd 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

KIM SNYDER, on behalf of herself and all others similarly situated, Civil No. 21-1049 (JRT/BRT)

Plaintiff, ORDER DENYING DEFENDANTS’ MOTION

TO DISMISS AND MOTION FOR v. SUMMARY JUDGMENT

UNITEDHEALTH GROUP, INC., BOARD OF DIRECTORS OF UNITEDHEALTH GROUP, INC., DAVID S. WINCHMANN, UNITEDHEALTH GROUP EMPLOYEE BENEFITS PLANS INVESTEMENT COMMITTEE, UNITEDHEALTH GROUP EMPLOYEE BENEFITS PLANS ADMINISTRATIVE COMMITTEE, DOES 1– 30,

Defendants.

Alexandra Harwin, SANFORD HEISLER SHARP, 1350 Avenue of the Americas, 31st Floor, New York, NY 10019; Charles Henry Field, Jr., SANFORD HEISLER SHARP, 2550 Fifth Avenue, 11th Floor, San Diego, CA 92103; David Sanford and R. Johan Conrad Jr., SANFORD HEISLER SHARP, 700 Pennsylvania Avenue Southeast, Suite 300, Washington DC 20003; Kevin H. Sharp and Leigh Anne, SANFORD HEISLER SHARP, St. Charles, 611 Commerce Street, Suite 3100, Nashville, TN 37203; Susan M. Coler, HALUNEN LAW, 80 South Eighth Street, Minneapolis, MN 55402, for plaintiff.

Brian D. Boyle and Meghan McLane VerGow, O’MELVENY & MYERS LLP, 1625 Eye Street Northwest, Washington DC 20006; Debora A. Ellingboe and Isaac B. Hall, FAEGRE DRINKER BIDDLE REATH LLP, 90 South Seventh Street, Suite 2200, Minneapolis, MN 55402, for defendants. Plaintiff Kim Snyder brought this class action on behalf of herself and all other similarly situated participants and beneficiaries of UnitedHealth Group, Inc.’s

(“UnitedHealth”) 401(k) Savings Plans (the “Plan”). Snyder brings this action for breach of fiduciary duties under ERISA against Defendants UnitedHealth, its Board of Directors and its members, David S. Winchmann, the UnitedHealth Group Employee Benefits Plans Investment Committee and its members, and the UnitedHealth Group Employee Benefits

Plans Administrative Committee and its members (collectively “Defendants”). Snyder alleges that Defendants breached their duty of prudence and duty to monitor the performance of individuals to whom they delegated fiduciary responsibilities.

Defendants have brought a Motion to Dismiss, or in the alternative, a Motion for Summary Judgment. Because Snyder has plausibly pled imprudence by identifying several meaningful benchmarks and demonstrating that the Wells Fargo Target Date Funds (the “Wells Fargo TDFs”) chronically underperformed each of these benchmarks over the

course of eleven years, the Court will deny Defendants’ Motion to Dismiss. As discovery has not yet begun, the Court will deny Defendants’ Motion for Summary Judgment as premature. BACKGROUND

I. FACTUAL BACKGROUND

UnitedHealth sponsors the Plan for 200,000 employees, former employees, and their beneficiaries. (Compl. at¶¶ 27–29, April 23, 2021, Docket No. 1.) Plan participants may make contributions to their retirement accounts and UnitedHealth matches those contributions. (Id. at ¶ 29.) The Plan has approximately $15 billion in assets under

management. (Id. at ¶ 30; Decl. of Meaghan VerGow (“VerGow Decl.”), Ex. 5 at Schedule H, June 23, 2021, Docket No. 43.) Snyder was a participant in the Plan during the Class Period and Defendants are the fiduciaries of the Plan. (Compl. at ¶ 12.) Participants of the Plan can select from various investment options for their 401(k),

one of which is a target date retirement fund. (Id. at ¶ 3; VerGow Decl., Ex. 8 at Schedule D.) A target date fund is designed to achieve certain investment results based on the investor’s anticipated retirement date. (Compl. at ¶ 4.) A target date fund employs a

glidepath which determines how the fund will allocate assets and risk over time, investing in less risky assets the closer a participant gets to their anticipated retirement date. (Id.) UnitedHealth’s target date funds are all managed by Wells Fargo. (Id. at ¶ 33.) UnitedHealth has designated the Wells Fargo TDFs as the default option for participants

of the Plan, so when a participant fails to select one of the other investment options for their 401(k), they are automatically enrolled into their respective Wells Fargo TDF. (Id. at ¶ 57.) Fidelity, T. Rowe Price, State Street, and Vanguard offer target date funds as well.

(Id. at ¶ 58.) Morningstar, a highly regarded financial services and research firm, classified these four target date funds (the “Morningstar Comparators”) as being within the same peer universe as the Wells Fargo TDFs. (Id. at ¶ 47.) Morningstar determined that the funds all had the same underlying portfolio holdings. (Id. at ¶ 48.) In reaching this conclusion, Morningstar considered: (1) the purpose of the target date funds; (2) how the

funds allocate assets among asset classes; and (3) how the funds intend to gradually reduce potential market risk exposure over time. (Id. at ¶ 49.) In order to analyze the performance of the Wells Fargo TDFs, UnitedHealth identified several benchmarks itself, including two indices: the S&P Target Date Indices

(“S&P Index”) and the Dow Jones Global Target Indices (“Dow Jones Index”). (Id. at ¶¶ 46, 63 n.10, 64.) UnitedHealth internally identified the Dow Jones Index as a benchmark, but never disclosed it to Plan participants. (Id.) The S&P Index, however, was disclosed

to Plan participants as a benchmark for the Wells Fargo TDFs beginning in 2018. (Id. at ¶ 46; Decl. of Kelly Bryant, Exs. 1–10, June 23, 2021, Docket No. 44.) The Complaint alleges that Wells Fargo TDF 2010 through 2060 each chronically underperformed these six different benchmarks over the course of eleven years. The

Complaint compiles 33 tables detailing this underperformance. (Compl. at Tables 1.a– 11.c.) As demonstrated by Table 5.a below, the Wells Fargo TDFs had a lower cumulative return and lower annualized return than every other comparator for the five years prior to the Class Period. (Compl. at Table 5.a.) Table 3.a October 1, 2010 December 31,2015 Fund ___| Cumulative Return | Annualized Return Wells Fargo Target 2030 41.52% FLAM Index Target Date 2030 T 48.00% 775% State Street Target Ret 2030 NL ‘C1 W 55.32% 8.75% T. Rowe Price Ret Hybrid 2030 Tr-T1 60.14% 0.38% Vanguard Target Retirement 2030 Trust I 56.86% 6.95% SP Target Date 2030 TR 52.91% 8.33% Dow Jones Global Target Date 2030 45.13% 7.35%

As illustrated in Table 5.b below, the Wells Fargo TDFs had a lower cumulative compound performance than all other benchmarks during the Class Period. (Compl. at Table 5.b.) Notably, though, the Wells Fargo TDFs did outperform some of the benchmarks in 2018 and 2021.1

1 The Complaint contains similar tables for Wells Fargo TDF 2010 through 2060. These tables all exhibit similar patterns of underperformance as the ones contained herein do.

Table 3.b January 1, 2016 — March 31, 2021

Annualized Performance Cumulative Compounded | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 Performance vers ee 15.45% 19.91%| 10.41% 59.35% FLAM Index Target Date $.68% | 17.99% | -5429% | 22.33% | 14.40% | 2.02% 73.16% 2030 T ++ Wells o 7 o470 7a 7 470 Farec -].55% | -2.54% | -0.02% | -242% | -3.99% | +0.89% -13.81% State Street Target Ret 8.20% | 17.98% | -6.71% | 21.72% | 17.53% | 1.90% 73.61% 2030 NL C1W notes | 1.07% 1.81% +1.01%| — -14.26% T. Rowe Price Ret Hybrid 8.75% | 19.22% | -6.15% | 22.62% | 16.25% | 4.12% 80.58% 2030 Tr-T1 Wells “a0 4778 8 779 27 9370 Farce -L.62% | -3.7 7% | +0. 71% | -2.71% | -5.b4% | -121% -32 235% Vanguard Target o. oO it, Reti 7.93% | 17.60% | -5.79% | 21.15% | 14.19% | 24AT% 69.50% 2030 Trost II =F Wells > 2 248 Faree -O.80% | -2.15% | +0. 35% | -L24% | -3.78% | +0.44% -LOL3% S&P Target Date Through | 9.08% | 17.38% | -6.52% | 21.76% | 11.82% | 3.48% 68.62% 2030 TR ++ Wells o a 0, a o a, 79 Farec -1.95% | -1.93% | +1.08% | -P.85% | -L4I% | -0.37% -9. 27%

uels 0.74% | +0.55% | -0.47% | -1.50% | -0.33%

Il.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Lavera Granetha Ashanti v. City of Golden Valley
666 F.3d 1148 (Eighth Circuit, 2012)
Ashley County, Ark. v. Pfizer, Inc.
552 F.3d 659 (Eighth Circuit, 2009)
Braden v. Wal-Mart Stores, Inc.
588 F.3d 585 (Eighth Circuit, 2009)
John Meiners v. Wells Fargo & Company
898 F.3d 820 (Eighth Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Snyder v. UnitedHealth Group, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/snyder-v-unitedhealth-group-inc-mnd-2021.